Photo from wikipedia
Recognition of a mixed hepatocellular-cholangiocarcinoma (HCC-CCA) in a candidate is generally considered a contraindication to liver transplantation (LT) due to a perception of poor posttransplant survival and high recurrence rates.1… Click to show full abstract
Recognition of a mixed hepatocellular-cholangiocarcinoma (HCC-CCA) in a candidate is generally considered a contraindication to liver transplantation (LT) due to a perception of poor posttransplant survival and high recurrence rates.1 Due to the relative rarity of these tumors and a lack of widely accepted and consistent diagnostic criteria, there is little published data to guide transplant consideration. This article is protected by copyright. All rights reserved.
Keywords:
hepatocellular cholangiocarcinoma;
transplantation;
liver transplantation;
consideration;
mixed hepatocellular
Journal Title: Liver Transplantation
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Liver Transplantation
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!